TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,389,392
|
2,084,988
|
1,788,092 |
Financial expenses |
119
|
11,947
|
6,196 |
Earnings before taxes |
180,438
|
84,381
|
76,554 |
EBITDA |
382,220
|
312,079
|
320,653 |
Total assets |
1,828,075
|
1,409,079
|
1,785,902 |
Current assets |
664,648
|
444,974
|
754,986 |
Current liabilities |
379,436
|
359,203
|
270,156 |
Equity capital |
1,162,768
|
1,020,582
|
952,997 |
- share capital |
25,000
![]() |
25,000
![]() |
25,000 |
Employees (average) |
1,065
|
984
|
882 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.6%
|
72.4%
|
53.4% |
Turnover per employee |
2,244
|
2,119
|
2,027 |
Profit as a percentage of turnover |
7.6%
|
4.0%
|
4.3% |
Return on assets (ROA) |
9.9%
|
6.8%
|
4.6% |
Current ratio |
175.2%
|
123.9%
|
279.5% |
Return on equity (ROE) |
15.5%
|
8.3%
|
8.0% |
Change turnover |
304,404
|
296,896
|
-98,147 |
Change turnover % |
15%
|
17%
|
-5% |
Chg. No. of employees |
81
|
102
|
-6 |
Chg. No. of employees % |
8%
|
12%
|
-1% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.